Collectively, these findings suggest that chemerin could be involved in the pathology of preeclampsia, while pravastatin and fluvastatin might serve as a potential treatment for preeclampsia, among others by suppressing chemerin (Figure 5F). Here, RARRES2 is linked to preeclampsia.